Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia

Case report: The efficiency and safety of lomitapide in a homozygous familial hypercholesterolemic child

(2019) Ana Paula M. Chacra et al.   Journal of Clinical Lipidology

Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps

(2019) Raul D. Santos et al.   ATHEROSCLEROSIS

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia

(2019) Tawfeg Ben-Omran et al.   ADVANCES IN THERAPY

Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017

(2018) Mariko Harada-Shiba et al.   Journal of Atherosclerosis and Thrombosis

Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia

(2018) Dirk J. Blom et al.   Orphanet Journal of Rare Diseases

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

(2018) Atsushi Nohara et al.   Journal of Atherosclerosis and Thrombosis

The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis

(2017) Robert Leipold et al.   European Journal of Preventive Cardiology

MTP Gene Variants and Response to Lomitapide in Patients with Homozygous Familial Hypercholesterolemia

(2016) Genovefa D Kolovou et al.   Journal of Atherosclerosis and Thrombosis

Calculation of LDL-Cholesterol vs. Direct Homogenous Assay

(2016) Mehdi Rasouli et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design

(2016) Dirk J. Blom et al.   Journal of Clinical Lipidology

Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia

(2016) P. Barton Duell et al.   Journal of Clinical Lipidology

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia

(2016) Anthony Wang et al.   Journal of the American Heart Association

Microsomal Transfer Protein Inhibitors, New Approach for Treatment of Familial Hypercholesterolemia, Review of the Literature, Original Findings, and Clinical Significance

(2015) Genovefa Kolovou et al.   Cardiovascular Therapeutics

The Agenda for Familial Hypercholesterolemia

(2015) Samuel S. Gidding et al.   CIRCULATION

Comparison of equations for the calculation of LDL-cholesterol in hospitalized patients

(2015) J. Martins et al.   CLINICA CHIMICA ACTA

Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia

(2015) Anna Raper et al.   Journal of Clinical Lipidology

Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide

(2015) Jeanine Roeters van Lennep et al.   Journal of Clinical Lipidology

Validation of a Proposed Novel Equation for Estimating LDL Cholesterol

(2014) J. W. Meeusen et al.   CLINICAL CHEMISTRY

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

The lower the better: Target values after LDL-Apheresis and semi-selective LDL-elimination therapies

(2013) Helmut Borberg   TRANSFUSION AND APHERESIS SCIENCE

Supra-valvular aortic stenosis in a patient with homozygous familial hypercholesterolaemia

(2013) Ravindran Rajendran et al.   European Heart Journal-Cardiovascular Imaging

Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment

(2012) Frederick J. Raal et al.   ATHEROSCLEROSIS

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

(2012) Marina Cuchel et al.   LANCET

Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population

(2010) Kozo Tanno et al.   CLINICA CHIMICA ACTA

Levels of proinflammatory cytokines and hs-CRP in patients with homozygous familial hypercholesterolaemia

(2009) D. Gokalp et al.   ACTA CARDIOLOGICA

Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology

(2009) Nalini M. Rajamannan   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY